CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 78,308	$ 114,916
Research and development incentive receivable	1,256	1,189
Prepaid expenses and other current assets	374	769
Total current assets	79,938	116,874
Property and equipment, net	24	36
Right-of-use assets, net	767	459
Deferred tax assets	142	159
Other long term assets	45	90
Deposits	1,249	293
Total assets	82,165	117,911
Current liabilities:
Accounts payable	6,276	4,189
Accrued expenses	5,042	5,366
Lease liability - current portion	405	432
Total current liabilities	11,723	9,987
Non current liabilities:
Lease liability, net of current portion	369	37
Total liabilities	12,092	10,024
Stockholders' equity:
Common stock, $0.001 par value; 240,000,000 shares authorized; 99,021,376 and 88,318,454 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	99	88
Additional paid-in capital	375,350	371,638
Accumulated other comprehensive income (loss)	690	(267)
Accumulated deficit	(306,066)	(263,572)
Total stockholders' equity	70,073	107,887
Total liabilities and stockholders' equity	$ 82,165	$ 117,911